Skip to content

CVRx, Inc. CVRX Operating Cash Flow

Operating Cash Flow at other companies

Abbott logo
AbbottABT
$1.32B-7.2%
Boston Scientific logo
Boston ScientificBSX
$348M-35.7%
Medtronic logo
MedtronicMDT
$2.57B+1.8%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$5.9M+21.1%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$17.61M+4.2%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$12.85M+292%

Other financials

Income statement

See full
Revenue$14.8M+19.6%
Gross profit$12.9M+24.9%
Operating income-$12.2M+9.5%
Net income-$13.1M+4.7%
EPS (diluted)-$0.50+5.7%

Balance sheet

See full
Cash & equivalents$72.3M-29.6%
Total debt$59.4M+17.8%
Total equity$29.1M-58.0%
Total assets$99.7M-23.0%

Cash flow

See full
CapEx$122.0K+7.0%
Free cash flow-$12.3M+4.6%

Valuation

See full
Market cap$148.6M-2.9%
Enterprise value$135.69M+25.0%
P/S2.5×-0.3×

Profitability

See full
Gross margin86.2%+2.7pp
Operating margin-84.6%-8.9pp
Net margin-89.1%-7.0pp
FCF margin-68%-8.1pp

Returns & leverage

See full
Return on equity-107%+73.4pp
Debt / equity+1.3×
Current ratio10.2×-4.6×

Where this comes from

Reported directly by CVRx, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: CVRx, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about CVRx, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CVRx, Inc.'s operating cash flow?
CVRx, Inc. (CVRX) reported operating cash flow of -$12.16M in Q1 2026.
How has CVRx, Inc.'s operating cash flow changed year-over-year?
CVRx, Inc.'s operating cash flow increased by 4.7% year-over-year, from -$12.77M to -$12.16M.
What is the long-term trend for CVRx, Inc.'s operating cash flow?
Over 4 years (2021 to 2025), CVRx, Inc.'s operating cash flow has grown at a 9.7% compound annual growth rate (CAGR), from -$27.73M to -$40.17M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.